Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3526 |
|
| Actual shortage: | 229 (6%) | |
| Anticipated shortage: | 3 (0%) | |
| Avoided shortage: | 11 (0%) | |
| Resolved: | 3283 (93%) | |
Discontinuation Reports |
366 |
|
| To be discontinued: | 24 (7%) | |
| Discontinued: | 342 (93%) | |
| Reversed: | 0 (0%) | |
Late reports |
143 (4%) |
|
Overdue reports |
32 (13%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2019-08-07 | 2019-09-23 | 91067 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2020-02-13 | 2020-06-08 | 105994 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2020-06-10 | 2020-06-15 | 117339 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2021-01-18 | 2021-03-15 | 131812 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2022-01-07 | 2022-03-28 | 152295 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2022-01-21 | 2022-04-01 | 153262 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2022-02-25 | 2022-03-29 | 155597 |
| APO-ATOMOXETINE | 60MG | CAPSULE | Resolved | 2022-02-25 | 2022-04-01 | 155600 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-06-02 | 2023-07-07 | 193600 |
| APO-ATOMOXETINE | 80MG | CAPSULE | Resolved | 2023-07-21 | 2023-08-18 | 199524 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-09-15 | 2023-12-01 | 204411 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2023-10-06 | 2023-12-01 | 206566 |
| APO-ATOMOXETINE | 100MG | CAPSULE | Resolved | 2024-05-24 | 2024-10-11 | 228792 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229164 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-05-30 | 2024-10-04 | 229167 |
| APO-ATOMOXETINE | 10MG | CAPSULE | Resolved | 2024-07-12 | 2024-09-27 | 232818 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2024-08-01 | 2024-10-04 | 234317 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-09-05 | 2024-10-04 | 236872 |
| APO-ATOMOXETINE | 25MG | CAPSULE | Resolved | 2024-11-07 | 2024-12-20 | 242211 |
| APO-ATOMOXETINE | 40MG | CAPSULE | Resolved | 2025-06-19 | 2025-06-27 | 260675 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| APO-PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| APO-TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| APO-TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |